← Back to Search

Procedure

Timing of Voiding Trials for Postoperative Urinary Retention

N/A

Recruiting

Research Sponsored by University of South Florida

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 2 years

Awards & highlights

Study Summary

This trial is testing if 30 or 60 minutes is best for patients to pass urine after surgery.

Who is the study for?

This trial is for women who can consent, speak English/Spanish, are having urogynecologic surgery at Tampa General Hospital and need a postoperative void trial. It's not for those under 18, unable to consent, staying overnight in the hospital, with urinary retention or neurogenic bladder history, imprisoned, or having certain non-standard procedures.Check my eligibility

What is being tested?

The study is testing if there's a difference in the ability to urinate after surgery between women given either 30 minutes or 60 minutes. Participants will be randomly assigned to one of these two groups before their scheduled urogynecologic procedure.See study design

What are the potential side effects?

Since this trial involves timing rather than medication or invasive therapy, there are no direct side effects from interventions being tested. However, general risks associated with postoperative care may still apply.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 2 years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~2 years

This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Pass Rate

Secondary outcome measures

Pass Rate After Failing

Surgical Procedures Performed Prior to Active Void Trial

Time in PACU

+1 more

Trial Design

2Treatment groups

Experimental Treatment

Group I: ImmediateExperimental Treatment1 Intervention

Patients will be given up to 30 minutes to void during the active void trial postoperatively.

Group II: ExtendedExperimental Treatment1 Intervention

Patients will be given up to 60 minutes to void during the active void trial postoperatively.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of South FloridaLead Sponsor

412 Previous Clinical Trials

186,851 Total Patients Enrolled

Media Library

Active Void Trial (Procedure) Clinical Trial Eligibility Overview. Trial Name: NCT05885958 — N/A

Postoperative Care Research Study Groups: Immediate, Extended

Postoperative Care Clinical Trial 2023: Active Void Trial Highlights & Side Effects. Trial Name: NCT05885958 — N/A

Active Void Trial (Procedure) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05885958 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any vacancies in the clinical trial that require participants?

"Correct. As per the evidence on clinicaltrials.gov, this medical trial is still enrolling patients and was initially posted on July 1st 2023 with an update made June 30th 2023. The research requires 208 participants from a single site to be recruited."

Answered by AI

To what extent is this research being conducted with participants?

"Affirmative, according to clinicaltrials.gov the trial is currently seeking out participants. First advertised on July 1st 2023 and last updated June 30th 2023, this study must recruit 208 people from a single location."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Timing of Active Void Trials After Urogynecologic Procedures

Simone Fertel 2023. "Timing of Active Void Trials After Urogynecologic Procedures". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05885958.